Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
J Surg Oncol
    May 2026

  1. Correction to "Comparison of a Risk Calculator With Frailty Indices in Patients Undergoing Lung Cancer Resection".
    J Surg Oncol. 2026 May 2. doi: 10.1002/jso.70140.
    >> Share


  2. Correction to "Comparison of a Risk Calculator With Frailty Indices in Patients Undergoing Lung Cancer Resection".
    J Surg Oncol. 2026 May 2. doi: 10.1002/jso.70137.
    >> Share

    March 2026
  3. SABARI J, Stiles BM
    Best Practices for the Multidisciplinary Care of Patients With Early-Stage Driver-Mutated Non-Small Cell Lung Cancer.
    J Surg Oncol. 2026 Mar 11. doi: 10.1002/jso.70214.
    >> Share


  4. RETRACTION: Comparison of a Risk Calculator With Frailty Indices in Patients Undergoing Lung Cancer Resection.
    J Surg Oncol. 2026 Mar 9. doi: 10.1002/jso.70232.
    >> Share

    February 2026
  5. NAKABACHI K, Shimizu H, Matsuoka M, Soma T, et al
    Clinical Outcomes and Surgical Procedures for Patients With Osteosarcoma and Metachronous Lung Metastasis: A Chronological Analysis.
    J Surg Oncol. 2026;133:210-216.
    >> Share

    January 2026

  6. Correction to "Circulating Levels of Galectin-9 Are a Potential Biomarker of Survival in Advanced Non-Small-Cell Lung Cancer".
    J Surg Oncol. 2026 Jan 12. doi: 10.1002/jso.70188.
    >> Share

    December 2025
  7. MIKUBO M, Tamagawa S, Kondo Y, Sonoda D, et al
    Clinical Significance and Preoperative Prediction of High-Grade Subtypes in Early-Stage Lung Adenocarcinoma Eligible for Sublobar Resection.
    J Surg Oncol. 2025;132:1407-1415.
    >> Share

    November 2025
  8. SIDHU H, Ding L, Rosenberg GM, Harano T, et al
    Safety of Minimally Invasive Sublobar Pulmonary Metastasectomy in the Frail Patient.
    J Surg Oncol. 2025;132:1173-1181.
    >> Share

    August 2025
  9. MOUSAVI SE, Yarahmadi D
    Comment On: "Clinical Course After Radical Local Therapy for Oligo-Recurrence of Nonsmall Cell Lung Cancer".
    J Surg Oncol. 2025 Aug 18. doi: 10.1002/jso.28153.
    >> Share

    April 2025
  10. KUSAMURA S, Cinquini M, Morris D, Piso P, et al
    Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for Evidence Evaluation and Recommendation.
    J Surg Oncol. 2025;131:810-815.
    >> Share

    March 2025
  11. SONODA D, Maruyama R, Kondo Y, Mitsuhashi S, et al
    Clinical Course After Radical Local Therapy for Oligo-Recurrence of Nonsmall Cell Lung Cancer.
    J Surg Oncol. 2025 Mar 30. doi: 10.1002/jso.28032.
    >> Share

  12. JIMENEZ M, Flandes J, van der Heijden EHFM, Ng CSH, et al
    Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection.
    J Surg Oncol. 2025 Mar 28. doi: 10.1002/jso.28110.
    >> Share

    February 2025
  13. DRIGOTAS C, Loftus AW, Ammori JB, Rothermel LD, et al
    Perfusion Strategies for Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.
    J Surg Oncol. 2025;131:310-315.
    >> Share

    January 2025
  14. FENG Y, Feng H, Ye J
    Economic Toxicity Associated With Cancer Treatments: Commentary on "Relationship of Surgical Approach With Financial Toxicity in Patients With Resected Lung Cancer".
    J Surg Oncol. 2025 Jan 8. doi: 10.1002/jso.28040.
    >> Share

    December 2024
  15. WOO W, Park B, Ahadi A, Chung LI, et al
    The Role of Pulmonary Metastasectomy for Non-Primary Lung Cancer: Umbrella Review of Meta-Analyses.
    J Surg Oncol. 2024 Dec 15. doi: 10.1002/jso.28033.
    >> Share

  16. DEBOEVER N, Eisenberg M, Niu J, Graber W, et al
    Conditional Survival of Patients With Early-Stage Non-Small Cell Lung Cancer Who Undergo Lobectomy, Segmentectomy, or Wedge Resection Using the NCDB.
    J Surg Oncol. 2024 Dec 5. doi: 10.1002/jso.27907.
    >> Share

    November 2024
  17. SU YD, Ma R, Fu YB, Wu HL, et al
    Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma.
    J Surg Oncol. 2024;130:1225-1234.
    >> Share

    October 2024
  18. VITELLO DJ, Logan CD, Zaza NN, Bates KR, et al
    Comparison of a Risk Calculator With Frailty Indices in Patients Undergoing Lung Cancer Resection.
    J Surg Oncol. 2024 Oct 10. doi: 10.1002/jso.27861.
    >> Share

  19. NAKAO M, Suzuki A, Ichinose J, Matsuura Y, et al
    Risk of Death From Other Diseases in Lung Cancer Patients After Sublobar Resection Versus Lobectomy.
    J Surg Oncol. 2024 Oct 2. doi: 10.1002/jso.27927.
    >> Share

    September 2024
  20. SCHIAVON M, Cannone G, Bertolaccini L, Gallina FT, et al
    Safety and Efficacy of Salvage Surgery after Treatment With Immune-Checkpoint Adjuvant Inhibitors for Advanced Non-Small Cell Lung Cancer: A Multicentric Study.
    J Surg Oncol. 2024 Sep 24. doi: 10.1002/jso.27920.
    >> Share

  21. DEBOEVER N, Eisenberg MA, Antonoff MB, Hofstetter WL, et al
    Relationship of Surgical Approach With Financial Toxicity in Patients With Resected Lung Cancer.
    J Surg Oncol. 2024 Sep 10. doi: 10.1002/jso.27870.
    >> Share

  22. SONG KJ, Faith I, Tuminello S, Taioli E, et al
    Patients With Surgically Resectable Lung Cancer Who Opt for Radiation Have Worse Outcomes.
    J Surg Oncol. 2024 Sep 10. doi: 10.1002/jso.27873.
    >> Share

  23. LIANG XL, Li XB, Fu YB, Su YD, et al
    Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review.
    J Surg Oncol. 2024;130:533-542.
    >> Share

  24. DE ALMEIDA DPA, Malta MFB, Cardoso WM, Leite ALDS, et al
    Metastatic benign leiomyoma: A case report of an uncommon presentation.
    J Surg Oncol. 2024;130:951-954.
    >> Share

    August 2024
  25. VITELLO DJ, Logan CD, Zaza NN, Bates KR, et al
    Comparison of a risk calculator with frailty indices in patients undergoing lung cancer resection.
    J Surg Oncol. 2024 Aug 29. doi: 10.1002/jso.27815.
    >> Share

    July 2024
  26. FILHO GVM, Costa GJ, Martins MR, Torres LC, et al
    Circulating levels of galectin-9 are a potential biomarker of survival in advanced non-small-cell lung cancer.
    J Surg Oncol. 2024 Jul 24. doi: 10.1002/jso.27758.
    >> Share

  27. MAMEDE I, Ribeiro L, Stecca C, Escalante-Romero L, et al
    Survival and pulmonary function in stage IA non-small cell lung cancer after sublobar resection versus lobectomy: An updated meta-analysis.
    J Surg Oncol. 2024 Jul 9. doi: 10.1002/jso.27767.
    >> Share

  28. PORTO DM, Costa GJ, Torres LC, Casarini DE, et al
    Immune checkpoint expression as prognostic biomarker candidates in non-small cell lung carcinoma patients.
    J Surg Oncol. 2024 Jul 7. doi: 10.1002/jso.27763.
    >> Share

    March 2024
  29. SAIKIA J, Malik PS, Kumar S, Jain D, et al
    Can cell-free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I-III a nonsmall cell lung cancer (NSCLC)? A pilot study.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27610.
    >> Share

    January 2024
  30. PEZESHKIAN F, McAllister M, Singh A, Theeuwen H, et al
    What's new in thoracic oncology.
    J Surg Oncol. 2024;129:128-137.
    >> Share

    December 2023
  31. GUPTA S, Wells SL, Jose AM, Seitter RH, et al
    High-dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial.
    J Surg Oncol. 2023;128:1141-1149.
    >> Share

  32. VAN DORP M, Unal S, Gooijer S, Dickhoff C, et al
    Salvage surgery for local recurrences after stereotactic ablative radiotherapy of colorectal pulmonary metastases.
    J Surg Oncol. 2023;128:1114-1120.
    >> Share

  33. MURAOKA Y, Yotsukura M, Yoshida Y, Nakagawa K, et al
    Dynamics of recurrence after curative resection of nonsmall cell lung cancer.
    J Surg Oncol. 2023;128:1205-1212.
    >> Share

    October 2023
  34. DEBOEVER N, Bayley EM, Eisenberg MA, Hofstetter WL, et al
    Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.
    J Surg Oncol. 2023 Oct 24. doi: 10.1002/jso.27490.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016